Welcome to Broadline Capital
Founded 16 years ago, Broadline Capital is a global alternative investment firm focused primarily on growth capital and impact investments. At Broadline, we're inspired by champions — people of vision and courage — whose ideas can positively change the world, and who are ready to transform their ideas into the next industry-changing company.
When evaluating opportunities, we seek companies that are positioned to thrive as the world continues to transition toward an economy increasingly driven by healthy living and the pursuit of a more efficient and sustainable way of life. We seek category leaders and category creators that are reshaping their industry, and prefer highly-charged sectors where innovation, growth, strong margins, and market consolidation are yielding abundant opportunities.
We place emphasis on identifying credible management teams who demonstrate the capability to benefit from our established platform, access to industry expertise, and vast network of relationships built over many years. Broadline's transaction leaders have spent their entire careers building trust-based relationships globally. They have led some of the most creative deals in their market categories. Their collective experience and relationships combine to support Broadline-sponsored companies to develop to the next level. We believe Broadline’s current investing opportunities are among the most exciting on the planet.
New York | Miami | Columbus | Seoul | Shanghai
Broadline Capital's proprietary investment process is designed to stretch alpha at every link of the investment value chain, from our multi-channel origination and transaction execution, to exit realization. Broadline's past success stems from our disciplined investment selection, our transaction team's creative mitigation structuring which tailors each deal to its unique situation, and our efforts to achieve alignment on a shared vision for a company that is mindful of varied stakeholders. When selecting opportunities, Broadline takes a two-pronged approach:
First, we start with a "Top-Down" view to identify categories positioned to grow and create broad impact as the world continues to transition toward an economy increasingly driven by healthy living and the pursuit of a more efficient and sustainable way of life, and where a combination of factors are generating an abundance of opportunities.
Next, we take a "Bottom-Up" view to spot category leaders and category creators helping to reshape their industry, and whose management teams display the credibility and readiness to benefit from our support while developing their business to the next level.
Broadline seeks less correlated investment risk by pursuing diversification across industries, geographies, transaction sizes, deal structures, development stages, and market capitalizations.
We invite you to scroll through case examples of portfolio companies below. If you are a current Broadline registered investor, please click on the "Investor Login" tab at the top of this website for management updates and reports from companies in your investment portfolio, and to review our current pipeline of investment opportunities.
Health & Life Sciences
Non-INVASIVE Medical Devices
Founded in 2006, EndoSphere is a medical technology company that has developed a first-in-class, non-invasive medical device that endoscopically treats one of the world's largest healthcare issues: Metabolic Diseases including Obesity, Type 2 Diabetes, and Fatty Liver Disease. Endosphere's flagship device, the SatiSphere™ system, is incisionless, reversible and repeatable. In clinical studies, the SatiSphere™ device has enabled Obese patients to achieve significant Excess Weight Loss (EWL) without the need for surgery, providing an alternative to traditional restrictive devices and bariatric surgeries. EndoSphere's portfolio of patent assets is 100% company-owned, and free from any third-party licensing or royalty obligations. EndoSphere received the medical device industry's inaugural "Fierce15" award, named by industry research firm FierceBiotech, which annually recognizes the world's 15 most promising privately-held medical innovations.
Novel Device Category: EndoSphere's novel "Endo-Metabolic" devices represent a completely new category of medical devices. Unlike traditional "Restrictive" devices, which work against nature, EndoSphere's Endo-Metabolic devices use the body's natural physiological responses to food intake to accelerate satiety and recalibrate brain-gut metabolic feedback loops. These devices are highly differentiated for their unique ability to amplify a patient's physiologic responses, regulate hormones, recalibrate satiety, and rebalance insulin levels.
Unique Focus on the Duodenum: Unlike other weight-loss treatments, which typically focus on restricting available capacity of the Stomach, EndoSphere focuses on the Duodenum, an important upper section of the small intestine, which is widely recognized as the body's Metabolic Control Center. The Duodenum plays important roles in multiple functions, including: Digestion, Appetite/Satiety regulation, Insulin management, and Drug Delivery.
EndoSphere's original version of its SatiSphere anti-obesity device received CE Mark regulatory approval in 31 countries, and the enhanced version of its product has already entered the clinical stages of development. For more information, please visit https://www.EndoSphereInc.com.
Environment & Sustainability
Founded in 2010, Powermers has developed the world's first Carbon-Free Lithium-ion Batteries by replacing the "deadweight" materials in conventional cathodes (the carbon and binders) with Powermers' proprietary nano-scale conductive polymer advanced materials. The result: measurably safer and high-performing batteries which have been independently-validated by the industry's recognized third-party battery testing labs, including the US Army Corps of Engineers' Battery Innovation Labs ("CERL") and The Ohio State University's Center for Automotive Research Labs ("OSU CAR"). Powermers' transition-metal polymers demonstrate higher catalytic functionality than pure noble-metal catalysts including gold, platinum, and palladium. Powermers owns 100% of its IP asset portfolio, free from any third-party licensing or royalty obligations. The independently-validated performance and safety results of Powermers' Carbon-free Lithium-ion Battery Technology have been published by the industry's peer-reviewed journal, the American Chemical Society (ACS) Applied Materials & Interfaces Journal.
Differentiated Safety: Powermers' technology improves safety for high-voltage Lithium-ion batteries by dramatically reducing Thermal Runaway Risk, the primary cause of high-voltage Lithium-ion batteries over-heating or exploding. In past years, Thermal Runaway Risk has caused billions of losses in value for high-profile companies such as Tesla and Samsung, whose customers place a high priority on product on battery safety.
Differentiated Performance: Replacing conventional "deadweight" components with our conductive polymer expands batteries' Active Material Limit, increasing Specific Energy without sacrificing any Power, Cycle Life, Weight, or Cost per KWH.
Total Cost Savings and Ease of Adoption for Battery Manufacturers: Powermers' polymers can be readily adopted by battery manufacturers, not requiring any significant change to established manufacturing steps while also achieving total cost savings.
For more information, please visit https://www.Powermers.com.
Broadline Capital's Transaction Leaders and Venture Partners are past CEOs and entrepreneurs who have previously founded and led successful companies, where they created significant value and negotiated quality exits for themselves and their investors. They have spent their entire careers building trust-based relationships globally, and have led some of the most creative deals in the history of their categories.
They understand what it takes to build a business from the ground up, because they've been there. Staying close to their roots as innovators and company operators, our Transaction Leaders and Venture Partners love collaborating with inspired and talented management teams and aligning varied stakeholders as they work together to build something special and to realize the shared vision for the company.
"At Broadline Capital, we are inspired by champions – people of vision and courage – whose ideas can positively change the world, and who are ready to transform their ideas into the next industry-changing company. If you share our perspective, we invite you to join us. We look forward to hearing from you."
MIAMI: Brickell City Tower, 80 SW 8th St., 20th Floor, Miami, FL 33131
MANHATTAN: 1 Rockefeller Plaza, 11th Floor, New York, NY 10020
Broadline ® is a Registered Trademark.
Copyright © Broadline Capital 2005-2021
All Rights Reserved.